G Schwab

A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

Reino Heikkilä, G Schwab, Eric Wickstrom et al. · Nature · 1987 · 691 citations

Molecular Physiology, Signal Transduction, Molecular Regulation +11

Randomized, Dose-Escalation Study of SD/01 Compared With Daily Filgrastim in Patients Receiving Chemotherapy

Eileen Johnston, Jeffrey Crawford, Susan Blackwell et al. · Journal of Clinical Oncology · 2000 · 267 citations

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation

Norbert Schmitz, Andrea Bacigalupo, Dirk Hasenclever et al. · Bone Marrow Transplantation · 1998 · 264 citations

Cell Therapy, Transplantation, Marrow Transplantation +8

A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans

Graham Molineux, Olaf Kinstler, Bob Briddell et al. · Experimental Hematology · 1999 · 239 citations

Knockout Mouse, Signal Transduction, New Form +10

Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition.

Luke Whitesell, S D Shifrin, G Schwab et al. · PubMed · 1992 · 176 citations

Glioma, Pharmaceutical Chemistry, Tumor Biology +17